Recombinant Rhesus Macaque CTSK Protein, His (Fc)-Avi-tagged
Cat.No. : | CTSK-914R |
Product Overview : | Recombinant Rhesus Macaque CTSK with His (Fc)-Avi tag was expressed and purified |
- Specification
- Gene Information
- Related Products
- Download
Source : | HEK293 |
Species : | Rhesus Macaque |
Tag : | His&Fc&Avi |
Endotoxin : | < 1.0 EU per μg of the protein as determined by the LAL method |
Purity : | ≥85% by SDS-PAGE |
Stability : | Stable for at least 6 months from the date of receipt of the product under proper storage and handling conditions. Avoid repeated freeze-thaw cycles. |
Storage : | For long term storage, aliquot and store at -20 to -80 centigrade. Avoid repeated freezing and thawing cycles. |
Storage Buffer : | PBS buffer |
Gene Name : | CTSK cathepsin K [ Macaca mulatta (Rhesus monkey) ] |
Official Symbol : | CTSK |
Synonyms : | CTSK; cathepsin K; cathepsin K preproprotein; |
Gene ID : | 574112 |
mRNA Refseq : | NM_001032812 |
Protein Refseq : | NP_001027984 |
UniProt ID : | G7MDI3 |
Products Types
◆ Recombinant Protein | ||
CTSK-440R | Active Recombinant Rat Ctsk Protein | +Inquiry |
CTSK-439R | Recombinant Rat CTSK Protein (115-329 aa), His-tagged | +Inquiry |
CTSK-9392H | Active Recombinant Human CTSK Protein | +Inquiry |
Ctsk-441R | Recombinant Rat Ctsk Protein | +Inquiry |
CTSK-1326R | Recombinant Rat CTSK Protein, His (Fc)-Avi-tagged | +Inquiry |
◆ Lysates | ||
CTSK-7192HCL | Recombinant Human CTSK 293 Cell Lysate | +Inquiry |
◆ Assay kits | ||
Kit-2352 | Cathepsin K Inhibitor Screening Kit (Fluorometric) | +Inquiry |
Related Gene
Not For Human Consumption!
Inquiry
- Reviews
- Q&As
Customer Reviews (3)
Write a reviewThis guidance can help researchers design and execute their experiments more effectively, ensuring reliable and accurate results.
They have a deep understanding of the CTSK protein and can provide valuable insights into its characteristics, properties, and optimal experimental conditions.
the manufacturer offers outstanding technical support, serving as a valuable resource to resolve any issues that may arise during my research.
Q&As (5)
Ask a questionYes, CTSK inhibitors are being investigated for their potential in preventing bone loss associated with periodontal diseases.
CTSK has been linked to vascular calcification in atherosclerosis, and inhibiting its activity may have potential as a therapeutic strategy for cardiovascular diseases.
CTSK inhibitors could potentially be used to limit bone destruction in cancer patients with bone metastasis, improving their quality of life.
CTSK inhibitors are being explored for potential therapeutic applications in conditions like rheumatoid arthritis and certain cancers due to their involvement in tissue remodeling.
While CTSK is not currently used as a diagnostic marker, its levels and activity could potentially be explored for diagnostic purposes in the future.
Ask a Question for All CTSK Products
Required fields are marked with *
My Review for All CTSK Products
Required fields are marked with *
Inquiry Basket